KECK MEDICINE OF USC

Dr. Amy Lee, Dr. Reginald Hill

Investigation of BOLD-100 Combination Therapy to Overcome Drug Resistance in Pancreatic Cancer

OUR COLLABORATORS

QUEEN’S UNIVERSITY BELFAST

Dr. Sandra Van Schaeybroeck

 Development of Biomarkers for Inhibitors of GRP78 for Poor Prognostic Colorectal Cancer Subgroups

UNIVERSITY OF PITTSBURG SCHOOL OF MEDICINE

Dr. Michael Lotze

Modulation of Immune Response with BOLD-100 and Combination Immunotherapyh

KECK MEDICINE OF USC

Dr. Amy Lee, Dr. Reginald Hill

Investigation of BOLD-100 Combination Therapy to Overcome Drug Resistance in Pancreatic Cancer

GEORGETOWN | LOMBARDI COMPREHENSIVE CANCER CRNTER

Dr. Ayesha Shajahan-Haq

Inhibition of DNA Repair Pathways in Breast Cancer is a Potential Mechanism of Action in Breast Cancer